Effects of brain natriuretic peptide on renin secretion in normal and hypertonic saline-infused kidney
- PMID: 1864303
- DOI: 10.1016/0014-2999(91)90613-u
Effects of brain natriuretic peptide on renin secretion in normal and hypertonic saline-infused kidney
Abstract
The effects of brain natriuretic peptide (BNP) on renin secretion were evaluated in normal and hypertonic saline-infused kidneys of anesthetized dogs. In the normal kidney (N = 5), intrarenal infusion of porcine BNP-(1-26) (pBNP) at a dose of 50 ng/kg per min attenuated the renin secretion rate significantly to 9 +/- 27% of control without exerting a significant effect on mean arterial pressure (MAP), renal blood flow (RBF) or glomerular filtration rate (GFR); urine flow (V) was significantly increased to 260 +/- 33% of control and urinary excretion of sodium (UNaV) to 480 +/- 140% of control. In the hypertonic saline infusion group (N = 6), intrarenal infusion of hypertonic saline (20% w/v) at 0.5, 0.8, and 1.0 mEq NaCl/min caused a decrease in GFR and natriuresis in a dose-dependent manner. The renin secretion rate was attenuated by hypertonic saline infusion (1 mEq NaCl/min) to 87 +/- 31% of control. In another group (N = 6), administration of pBNP at a dose of 50 ng/kg per min during hypertonic saline infusion (1 mEq NaCl/min) increased the renin secretion rate to 196 +/- 57%, increased RBF to 160 +/- 13%, increased GFR to 137 +/- 22%, increased V to 221 +/- 29%, and increased UNaV to 218 +/- 29% of the values measured during hypertonic saline infusion. Our results indicate that BNP inhibits renin secretion through sodium delivery to the macula densa and effectively inhibits the tubuloglomerular feedback response that is activated by intrarenal hypertonic saline infusion.
Similar articles
-
Intrarenal hypertonic saline infusions in dogs with thoracic caval constriction.Kidney Int. 1987 Oct;32(4):488-92. doi: 10.1038/ki.1987.236. Kidney Int. 1987. PMID: 3430950
-
Renal mechanisms for suppression of renin secretion by atrial natriuretic factor.Hypertension. 1986 Jun;8(6 Pt 2):II28-35. doi: 10.1161/01.hyp.8.6_pt_2.ii28. Hypertension. 1986. PMID: 2941371
-
Diuretic response of a second infusion of atrial natriuretic polypeptide into anesthetized dogs.Nephron. 1987;45(2):135-9. doi: 10.1159/000184095. Nephron. 1987. PMID: 2951604
-
Effects of hyperosmotic mannitol infusion on hemodynamics of dog kidney.Anesth Analg. 1996 May;82(5):902-8. doi: 10.1097/00000539-199605000-00002. Anesth Analg. 1996. PMID: 8610896
-
Atriopeptins as cardiac hormones.Hypertension. 1985 Jul-Aug;7(4):469-82. doi: 10.1161/01.hyp.7.4.469. Hypertension. 1985. PMID: 2989170 Review. No abstract available.
Cited by
-
Potential and Limitations of Atrial Natriuretic Peptide as Biomarker in Pediatric Heart Failure-A Comparative Review.Front Pediatr. 2019 Jan 29;6:420. doi: 10.3389/fped.2018.00420. eCollection 2018. Front Pediatr. 2019. PMID: 30761275 Free PMC article. Review.
-
Nesiritide improves hemodynamics in children with dilated cardiomyopathy: a pilot study.Pediatr Cardiol. 2009 Jan;30(1):26-34. doi: 10.1007/s00246-008-9272-6. Epub 2008 Aug 15. Pediatr Cardiol. 2009. PMID: 18704555 Clinical Trial.
-
Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.Drug Saf. 2007;30(9):765-81. doi: 10.2165/00002018-200730090-00004. Drug Saf. 2007. PMID: 17722969 Review.
-
Clinical Significance of B-Type Natriuretic Peptide and N-Terminal Pro-B-Type Natriuretic Peptide in Pediatric Patients: Insights into Their Utility in the Presence or Absence of Pre-Existing Heart Conditions.Int J Mol Sci. 2024 Aug 12;25(16):8781. doi: 10.3390/ijms25168781. Int J Mol Sci. 2024. PMID: 39201467 Free PMC article. Review.
-
Genome-wide association analysis of plasma B-type natriuretic peptide in blacks: the Jackson Heart Study.Circ Cardiovasc Genet. 2015 Feb;8(1):122-30. doi: 10.1161/CIRCGENETICS.114.000900. Epub 2015 Jan 5. Circ Cardiovasc Genet. 2015. PMID: 25561047 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources